Revlon Report issue

For profit Phase 3
Founded: New York NY United States (1931)
Status: Acquired by Rorer (1985) → now Sanofi-Aventis (2004)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
None

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (2)

Key: Revlon (0) Acquired (2)

atorvastatin (lipitor) (1 trial)

levocarnitine (carnitor) (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 1
  • # of Trial APIs: 2